Press Releases

WALTHAM, Mass., Sept. 3, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc., the world leader in serving science, announces its support of Sepsis Awareness Month to drive awareness around sepsis, a complex clinical syndrome and a leading cause of death globally.1Throughout the month of September, supporters are encouraged to join together to raise seps

SAN JOSE, Calif., Sept. 3, 2019 /PRNewswire/ -- Thermo Fisher Scientific, the world leader in serving science, and Cedars-Sinai, a leading nonprofit academic healthcare organization, have enter

ISFIYA, Israel, Sept. 3, 2019 /PRNewswire/ -- Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKW), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of the C-Scan® System, the first and only preparation-free ingestible scanning capsule based system for the prevention of colorectal cancer through the dete

CAESAREA, Israel, Sept. 3, 2019 /PRNewswire/ -- IceCure Medical Ltd. (TASE: ICCM), developer of the next generation cryoablation technology to treat malignant and benign tumors by freezing without the need for surgery, announced today an exclusive distribution agreement with leading global medical company, Terumo Corporation (Tokyo: 4543

SAN DIEGO, Sept. 3, 2019 /PRNewswire/ -- Histogen, Inc., a regenerative medicine company focused on stimulating the body's stem cells to regenerate tissues, announced today that it will be featured as a presenting company at the 21st Annual Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The conference is being held on

STRASBOURG, France, Sept. 3, 2019 /PRNewswire/ -- Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, today announced the appointment of David Garrett, MBA, CPA, as Chief Financial Officer. Mr. Garrett will be bas

IRVINE, Calif., Sept. 3, 2019 /PRNewswire/ -- Laboratory for Advanced Medicine (LAM), a commercial-stage medical technology company with innovative technologies for the early diagnosis of cancer, today announced that its Liver Cancer detection test has been granted Breakthrough Device designation by the U.S. Food and Drug Administration (FDA). The liquid biopsy blo

BOTHELL, Wash., Sept. 3, 2019 /PRNewswire/ -- BioLife Solutions

SAN DIEGO, Sept. 3, 2019 /PRNewswire/ -- Inhibrx, Inc. (Inhibrx), a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates, announced today the completion of the dose escalation portion of its Phase 1 clinical trial of INBRX-109. INBRX-109 is a multivalent agonist of death receptor 5 (DR5) in development

SAN DIEGO, Sept. 3, 2019 /PRNewswire/ -- Aristea Therapeutics (Aristea), a clinical-stage drug development company developing novel therapies to treat serious inflammatory diseases, today announced the appointment of Nihar Bhakta, M.D. as Chief Medical Officer.  In his new role, Dr. Bhakta will be responsible for leading and expanding